Page 4 - Heart Failure Guidelines
P. 4

Pediatric Heart Failure Guidelines

               Table of Contents

               Preface ...................................................................................................................................... 3
               Heart Failure - General Considerations ...................................................................................... 6
                  Initial Evaluation ..................................................................................................................... 6
                  Disease Staging for Infants & Children ................................................................................... 6
                  Symptom Severity Classification ............................................................................................. 7
                  Genetics Evaluation ................................................................................................................ 7
                  Medications ............................................................................................................................ 8
                  Anticoagulation ......................................................................................................................12
                  Nutrition .................................................................................................................................12
                  Exercise ................................................................................................................................13
                  Advanced Therapies ..............................................................................................................16
                  Follow-up Schedule ...............................................................................................................17
                  Mental Health Screening .......................................................................................................18
               Dilated Cardiomyopathy (DCM) ................................................................................................19

                  Additional Evaluation for DCM ...............................................................................................19
                  Medical Management DCM ...................................................................................................19
                  Follow-up Schedule for DCM .................................................................................................19
               Hypertrophic Cardiomyopathy (HCM) .......................................................................................20

                  Additional Diagnostic Evaluation for HCM .............................................................................20
                  Management HCM ................................................................................................................20
                  References ............................................................................................................................21
                  Obstruction Algorithm ............................................................................................................22
                  ICD Algorithm ........................................................................................................................23
                  Follow-up Schedule for Hypertrophic Cardiomyopathy ..........................................................24
               Restrictive Cardiomyopathy (RCM) ...........................................................................................24

                  Additional Evaluation for RCM ...............................................................................................24
                  Medical Management RCM ...................................................................................................24
                  Follow-up Schedule for Restrictive Cardiomyopathy ..............................................................25

               Non-Compaction Cardiomyopathy (LVNC) ................................................................................26
                  Additional Evaluation for LVCN .............................................................................................26
                  Medical Management for LVCN .............................................................................................26
                  Follow-up Schedule for LVCN ...............................................................................................26

               Congenital Heart Disease with Heart Failure .............................................................................27
                  Additional Evaluation for CHD with Heart Failure ...................................................................27
                  Management and Long-Term Follow-up for CHD with Heart Failure ......................................27
               Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) ......................................................28
                  Additional Evaluation for ARVC .............................................................................................28
                  Medical Management for ARVC ............................................................................................28
                  Follow up for ARVC ...............................................................................................................28




               Updated 12/4/2018                                                                       page 4
   1   2   3   4   5   6   7   8   9